Keyword

survodutide

Description: Survodutide is an investigational dual glucagon and GLP-1 receptor agonist studied as a treatment for obesity and metabolic liver disease.
Wikidata ID: wiki/Q123907235
OpenAlex ID: keywords/survodutide
2024 · Arun J. Sanyal, Pierre Bedossa, et al. · New England Journal of Medicine · 593
2024 · Daniel J. Drucker · Diabetes Care · 458
2025 · Philip N. Newsome, Rohit Loomba · Journal of Clinical Investigation · 90
2025 · Jang Won Son, Carel W le Roux, et al. · Endocrine Reviews · 44
2024 · Mikhail N. Kosiborod, Elke Platz, et al. · JACC Heart Failure · 42
2026 · Carel W. le Roux, Sean Wharton, et al. · New England Journal of Medicine · 33
2023 · Thomas Klein, Robert Augustin, et al. · Diabetes Research and Clinical Practice · 27
2025 · Riad Mohammed Abdelrahman, Taha Hussein Musa, et al. · Journal of Obesity · 24
Works count: 276
Citation count: 2,558
Year
Topic
Type